At a glance

ClinicalIndex Comparison Record

N/ACompleted· 36 enrolled

Drug / intervention

Continuous glucose monitoring systemdevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03251079

NCT03251079N/ACompleted

Compare CT.gov

PRECISION Study: A Prospective, Multi-center Evaluation of Precision, Compression and Performance of a Novel Implanted Continuous Glucose Sensor Using a Next Generation Transmitter and Algorithm

Senseonics, Inc.·interventional·Posted Aug 16, 2017·Updated Feb 12, 2024

In Brief

A clinical study evaluating Continuous glucose monitoring system for Diabetes Mellitus and 2 related conditions. Completed, enrolled 36 participants across 3 sites.

Detailed Summary

The purpose of this multi-center, prospective clinical study is to evaluate the performance of a novel, implanted Senseonics continuous glucose monitoring system (Senseonics CGM System) compared to Yellow Springs Instrument (YSI) glucose analyzer reference standard measurements using a next generation transmitter and algorithm. Other measures evaluated will be the effects of compression on performance and the safety of the Senseonics CGM system.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

201820192020202120222023202420252026

Enrollment StartJul 2017

First PostedAug 2017

Primary CompletionFeb 2018

TodayJul 2026

First PostedAug 16, 2017

Enrollment StartJul 25, 2017

Primary CompletionFeb 1, 2018

TodayJul 2, 2026

Enrollment to primary: 6 monthsPosted 8.9 years ago

Interventions

Continuous glucose monitoring systemdevice

Implanted continuous glucose monitoring system